Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination. Continue your routine care with us by scheduling an in-person appointment or Video Visit.

Dr. Landau Receives The Mark Foundation’s 2022 Emerging Leader Award

Dr. Dan Landau

Dr. Dan Landau, Associate Professor of Medicine, Divion of Hematology and Medical Oncology, has received the prestigious 2022 Emerging Leader Award from The Mark Foundation.

Providing $250,000 per year over three years, the award will support Dr. Landau’s development of novel technology to study clonal mosaicism in normal tissues. This research will open a critical window into the earliest stages of cancer formation.

The Mark Foundation states that Dr. Landau’s application of “novel single-cell sequencing technologies to study the mechanisms underlying the growth advantage in cancer” will fill a “gap in knowledge” regarding cancer mutations and their growth.

An oncologist and a Core Member of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center, Dr. Landau’s long-term goal is to develop novel technologies to address cancer evolution as a central obstacle to cure. He received his M.D. from the Sackler School of Medicine at Tel Aviv University and a Ph.D. in Cancer Biology from Paris Diderot University. He completed his residency in Internal Medicine and a fellowship in hematology and medical oncology at Yale University and was a postdoctoral fellow in cancer genomics at the Dana-Farber Cancer Institute and the Broad Institute.